CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Emmaus Life Sciences, Inc.

EMMA
$2MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for EMMA. That does not mean none is planned.

Get an email about EMMA's next catalysts

Track Emmaus Life Sciences (EMMA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaTORRANCE32 employees
Drug Pipeline

Frequently asked questions

What is in Emmaus Life Sciences, Inc.'s drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Emmaus Life Sciences, Inc.'s (EMMA) pipeline across Phase 3. Its lead program is L-glutamine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Emmaus Life Sciences, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Emmaus Life Sciences, Inc. (EMMA) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track EMMA biotech catalysts?β†’

Add EMMA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Emmaus Life Sciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply